Related Experiment Video
Updated: Oct 17, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
MicroRNAs in Lupus Nephritis-Role in Disease Pathogenesis and Clinical Applications
Benjamin Y F So1, Desmond Y H Yap1, Tak Mao Chan1
1Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Abstract:
MicroRNAs (miRs) are non-coding small RNAs that act as epigenetic modulators to regulate the protein levels of target mRNAs without modifying the genetic sequences. The role of miRs in the pathogenesis of lupus nephritis (LN) is increasingly recognized and highly complex. Altered levels of different miRs are observed in the blood, urine and kidney tissues of murine LN models and LN patients. Accumulating evidence suggests that these miRs can modulate immune cells and various key inflammatory pathways, and their perturbations contribute to the aberrant immune response in LN. The dysregulation of miRs in different resident renal cells and urinary exosomes can also lead to abnormal renal cell proliferation, inflammation and kidney fibrosis in LN. While miRs may hold promise in various clinical applications in LN patients, there are still many potential limitations and safety concerns for their use. Further studies are worthwhile to examine the clinical utility of miRs in the diagnosis, disease activity monitoring, prognostication and treatment of LN.
Insights
MicroRNAs (miRs) are key epigenetic regulators implicated in lupus nephritis (LN) pathogenesis. Further research is needed to explore their clinical utility in diagnosing and treating LN.
Area of Science:
- Epigenetics
- Molecular Biology
- Nephrology
Background:
- MicroRNAs (miRs) are small non-coding RNAs regulating gene expression epigenetically.
- Their role in lupus nephritis (LN) pathogenesis is complex and increasingly recognized.
- Altered miRs are detected in blood, urine, and kidney tissues of LN models and patients.
Purpose of the Study:
- To summarize the current understanding of miRs in lupus nephritis.
- To highlight the contribution of miRs to immune dysregulation and renal pathology in LN.
- To discuss the potential and limitations of miRs in clinical applications for LN.
Main Methods:
- Review of existing literature on miRs and lupus nephritis.
- Analysis of miR expression patterns in LN models and patients.
- Examination of miR functions in immune cells and renal cells.
Main Results:
- miRs modulate immune cells and inflammatory pathways, contributing to LN pathogenesis.
- Dysregulated miRs in renal cells and exosomes promote renal cell proliferation, inflammation, and fibrosis.
- miRs show potential for clinical applications in LN diagnosis, monitoring, and treatment.
Conclusions:
- miRs play a significant role in the complex pathogenesis of lupus nephritis.
- Further investigation is crucial to address limitations and safety concerns for clinical miR utility in LN.
- miRs may offer future diagnostic, prognostic, and therapeutic strategies for LN patients.
More Related Videos
Related Concept Videos
MicroRNAs
The JAK-STAT Signaling Pathway
Nephrotic Syndrome I : Introduction

